Monitor for any follow-up filings related to the recent officer departure or the outcome of the annual meeting vote.
RCUS drugs
RCUS drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Apr 22 $26.62entry
- T+1 · 7mo ago −5.60%α −5.20% · $25.13
- T+5 · 7mo ago −7.79%α −7.85% · $24.55
- T+20 · 6mo ago −14.54%α −17.70% · $22.75
- T+60 · 4mo ago +2.82%α −1.96% · $27.37
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Arcus Biosciences, Inc. is holding its 2026 Annual Meeting to vote on director elections, auditor appointment ratification, and executive compensation. This is a routine proxy filing, not a shareholder vote outcome. A recent officer departure filing suggests potential governance issues, but the proxy itself is standard.
Key Financial Metrics
Key Facts
- Filing is a DEFA14A, the definitive proxy statement for the 2026 Annual Meeting.
- Vote items include the election of four directors, ratification of Ernst & Young as auditors, and advisory approval of executive compensation.
- A recent 8-K filing (March 23, 2026) reported the departure of an officer, which may indicate internal changes.
- The filing is routine and does not contain material financial information or significant strategic announcements.
Financial Impact
No material financial impact from this filing.
Risk Factors
- The recent officer departure may indicate potential governance or strategic instability.
- The outcome of the shareholder vote, while expected to pass, could be influenced by activist sentiment if present.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001724521-26-000026 |
| Document: 0001724521-26-000026-index-headers.html | 0001724521-26-000026 |
| Document: 0001724521-26-000026-index.html | 0001724521-26-000026 |
| Document: 0001724521-26-000026.txt | 0001724521-26-000026 |
Track record
13 reports on RCUS
2 of 4 bullish or bearish reports moved the stock their way by T+5. Best: +4.24% at T+1 after the Oct 21, 2026 report. 2 of 4 went positive at some point.
Filters
- Nov 16, 2026today Institutional Cluster Neutral 3/10 Entry $16.95 Now $16.86 −0.53% settles Nov 23
- Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Entry $18.95 to $16.86 Now $16.86 −11.03% ▼ −11.03% −9.34% vs SPY
- Nov 4, 202612d ago 8-K Neutral 5/10 Entry $17.69 to $17.77 Now $16.86 −4.69% ▲ +0.45% −2.84% vs SPY
- Oct 23, 202624d ago 8-K Bearish 5/10 Entry $17.76 to $18.19 Now $16.86 +5.07% ▼ −2.42% −3.68% vs SPY
- Oct 22, 202625d ago 424B5 Bearish 6/10 Entry $18.54 to $18.19 Now $16.86 +9.06% ▲ +1.89% +1.33% vs SPY
- Oct 21, 202626d ago 424B5 Bearish 5/10 Entry $19.36 to $18.61 Now $16.86 +12.91% ▲ +3.87% +4.58% vs SPY
- Oct 21, 202626d ago 8-K Neutral 4/10 Entry $19.36 to $18.61 Now $16.86 −12.91% ▼ −3.87% −4.58% vs SPY
- Oct 20, 202627d ago 8-K Neutral 4/10 Entry $23.75 to $18.14 Now $16.86 −29.01% ▼ −23.62% −23.70% vs SPY
- Jul 9, 202618w ago 144 Neutral 3/10 Entry $28.92 to $26.64 Now $16.86 −41.70% ▼ −7.88% −7.32% vs SPY
- Apr 21, 202629w ago DEFA14A Neutral 2/10 Viewing Entry $26.62 to $24.55 Now $16.86 −36.66% ▼ −7.79% −7.85% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers